NO992526D0 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
NO992526D0
NO992526D0 NO992526A NO992526A NO992526D0 NO 992526 D0 NO992526 D0 NO 992526D0 NO 992526 A NO992526 A NO 992526A NO 992526 A NO992526 A NO 992526A NO 992526 D0 NO992526 D0 NO 992526D0
Authority
NO
Norway
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
NO992526A
Other languages
Norwegian (no)
Other versions
NO992526L (en
Inventor
Dane M Springer
Bing Y Luh
Andrea Stanley V D
Thomas W Hudyma
Oak K Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO992526L publication Critical patent/NO992526L/en
Publication of NO992526D0 publication Critical patent/NO992526D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992526A 1996-11-27 1999-05-26 Cephalosporin derivatives NO992526D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
PCT/US1997/021785 WO1998023621A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Publications (2)

Publication Number Publication Date
NO992526L NO992526L (en) 1999-05-26
NO992526D0 true NO992526D0 (en) 1999-05-26

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992526A NO992526D0 (en) 1996-11-27 1999-05-26 Cephalosporin derivatives

Country Status (17)

Country Link
EP (1) EP0966472A1 (en)
JP (1) JP2001506607A (en)
KR (1) KR20000057283A (en)
CN (1) CN1238775A (en)
AR (1) AR010650A1 (en)
AU (1) AU734948B2 (en)
BR (1) BR9713350A (en)
CA (1) CA2272717A1 (en)
CZ (1) CZ185399A3 (en)
HU (1) HUP9903621A3 (en)
IL (1) IL129437A0 (en)
NO (1) NO992526D0 (en)
NZ (1) NZ335892A (en)
PL (1) PL334558A1 (en)
TW (1) TW414796B (en)
WO (1) WO1998023621A1 (en)
ZA (1) ZA9710662B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085180A (en) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 Novel cephalosporin antibiotics and process for preparing same
KR20020085178A (en) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 Novel cephalosporin antibiotics and process for preparing same
KR20020085181A (en) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 Novel cephalosporin antibiotics and process for preparing same
KR20020085176A (en) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 Novel cephalosporin antibiotics and process for preparing same
KR20030071311A (en) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 Novel cephalosporin compounds and process for preparing the same
MX2013013211A (en) * 2011-05-18 2014-02-20 Syngenta Participations Ag Insecticidal compounds based on arylthioacetamide derivatives.
CN105131018B (en) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 A kind of preparation method of ceftezole acid
CN114957056A (en) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 Process for preparing methyl 3-methyl-2-chloro-4-methylsulfonylbenzoate and intermediates thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
WO1997022611A1 (en) * 1995-12-20 1997-06-26 Bristol-Myers Squibb Company Cephalosporin derivatives

Also Published As

Publication number Publication date
NO992526L (en) 1999-05-26
ZA9710662B (en) 1999-05-26
BR9713350A (en) 2000-01-25
AU5365298A (en) 1998-06-22
PL334558A1 (en) 2000-03-13
NZ335892A (en) 2001-07-27
CN1238775A (en) 1999-12-15
TW414796B (en) 2000-12-11
EP0966472A1 (en) 1999-12-29
CA2272717A1 (en) 1998-06-04
HUP9903621A2 (en) 2000-04-28
CZ185399A3 (en) 1999-08-11
WO1998023621A1 (en) 1998-06-04
KR20000057283A (en) 2000-09-15
AR010650A1 (en) 2000-06-28
AU734948B2 (en) 2001-06-28
HUP9903621A3 (en) 2001-05-28
JP2001506607A (en) 2001-05-22
IL129437A0 (en) 2000-02-17
EP0966472A4 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
DE69735712D1 (en) ARYL-PYRIMIDINE DERIVATIVES
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
PT934320E (en) NAFTIRIDINE DERIVATIVES
BR9712037A (en) Piperazine derivatives
NO981946D0 (en) Imidazoquinazolin derivatives
EE9800219A (en) New 19-nor-pregnene derivatives
NO952854D0 (en) 1-arylpyrimidin derivatives
DE59508427D1 (en) 3-ARYL-4-HYDROXY-DELTA 3 -DIHYDROTHIOPHENONE DERIVATIVES
DE69732576D1 (en) TETRAHYDROBENZINDOLON DERIVATIVES
BR9709065A (en) Alkylaminobenzothiazole derivatives e-benzoxazole
DE69430587D1 (en) PYRIMIDINE-ACYCLONUKLEOSID DERIVATIVES
NO963805D0 (en) cephalosporin
IS5026A (en) 2-methoxyphenylpiperazine derivatives
NO992526D0 (en) Cephalosporin derivatives
PT931087E (en) NEW PYRANOSID DERIVATIVES
DE69527786T2 (en) DIAMINOMETHYLIDEN DERIVATIVES
PT906279E (en) PIRROL DERIVATIVES
DE59509209D1 (en) DIPHENYLOXAZOLINE DERIVATIVES
DE69510792T2 (en) NAPHTOCHINONE DERIVATIVES
BR9706980A (en) Isooxacefem derivatives
BR9708310A (en) 2-Thioxotetrahydropyrimidin-4-one derivatives
DE69706321D1 (en) CEPHEM DERIVATIVES
NO993024L (en) The polysaccharide-peptide derivatives
DE69710921T2 (en) HETEROCYCLIC SUBSTITUTED PYRROLIDINAMIDE DERIVATIVES
ATA69896A (en) 3-METHYLIMINO-3-CEPHEM DERIVATIVES 3-METHYLIMINO-3-CEPHEM DERIVATIVES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application